iBio (IBIO) Revenue (2011 - 2025)

iBio's (IBIO) quarterly Revenue came in at $100000.0 in Q3 2025, down 50.0% on a QoQ basis from $200000.0 in Q2 2025.

iBio (IBIO) Revenue (2011 - 2025) Analysis & Trends

iBio (IBIO) has 15 years of Revenue data on file, last reported at $100000.0 in Q3 2025.

  • On a quarterly basis, Revenue changed N/A year-over-year to $100000.0 in Q3 2025; TTM through Mar 2026 was $300000.0, a 20.0% decrease from a year earlier, with the FY2025 full-year figure at $400000.0, up 77.78% from the prior year.
  • Revenue for Q3 2025 stood at $100000.0, down from $200000.0 in the prior quarter.
  • Over the last five years, Revenue for IBIO reached as high as $1.8 million in Q1 2022 and fell as low as $50000.0 in Q3 2023.
  • Historically, Revenue has averaged $429444.4 across 5 years, with a median of $200000.0 in 2024.
  • On a YoY basis, Revenue climbed as much as 696.88% in 2021 and fell as far as 79.51% in 2021.
  • Year by year, Revenue stood at $84000.0 in 2021, then soared by 2042.86% to $1.8 million in 2022, then sank by 97.22% to $50000.0 in 2023, then soared by 300.0% to $200000.0 in 2024, then slumped by 50.0% to $100000.0 in 2025.
  • Per Business Quant data, the three most recent Revenue figures were $100000.0 in Q3 2025, $200000.0 in Q2 2025, and $200000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - -
2 Nanobiotix 1,911.11 Bn 1,911.05 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 467.81 Bn 463.02 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 122.92 Bn 115.68 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 70.28 Bn 61.53 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.88 Bn 62.88 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 1.56 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 1.17 Bn
10 iBio 163.25 Mn 163.25 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 100,000.00
Jun 30, 2025 200,000.00
Dec 31, 2024 200,000.00
Jun 30, 2024 175,000.00
Sep 30, 2023 50,000.00
Mar 31, 2022 1.80 Mn
Sep 30, 2021 84,000.00
Jun 30, 2021 491,000.00
Mar 31, 2021 765,000.00
Dec 31, 2020 705,000.00
Sep 30, 2020 410,000.00
Jun 30, 2020 1.12 Mn
Mar 31, 2020 96,000.00
Dec 31, 2019 314,000.00
Sep 30, 2019 108,000.00
Jun 30, 2019 795,000.00
Mar 31, 2019 527,000.00
Dec 31, 2018 651,000.00
Sep 30, 2018 45,000.00
Jun 30, 2018 91,000.00